Related content

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan

By Ichinose Yukito  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 43-48

Springer Publishing Company

Access to resources Recommend Favorite

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

By Zatloukal P.   Petruzelka L.   Zemanova M.   Kolek V.   Skrickova J.   Pesek M.   Fojtu H.   Grygarkova I.   Sixtova D.   Roubec J.   Horenkova E.   Havel L.   Prusa P.   Novakova L.   Skacel T.V.   Kuta M.  

Lung Cancer, Vol. 41, Iss. 3, 2003-09 ,pp. : 321-331

Elsevier

Access to resources Recommend Favorite

Surveillance of resected non-small cell lung cancer

By López-González A.  

Clinical and Translational Oncology, Vol. 14, Iss. 10, 2012-10 ,pp. : 721-725

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of docetaxel and vinorelbine as adjuvant chemotherapy for resected non-small cell lung cancers

By Chaft Jamie   Rekhtman Natasha   Sima Camelia   Rusch Valerie   Kris Mark   Zakowski Maureen   Azzoli Christopher  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 4, 2013-10 ,pp. : 931-934

Springer Publishing Company

Access to resources Recommend Favorite

Spinal Infarction Related to the Adjuvant Chemotherapy for Surgically Resected Non-small Cell Lung Cancer: Report of a Case

By Matsutani Noriyuki   Kawamura Masafumi  

Japanese Journal of Clinical Oncology, Vol. 43, Iss. 5, 2013-05 ,pp. : 569-570

Oxford University Press

Access to resources Recommend Favorite